121 related articles for article (PubMed ID: 15008947)
1. AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.
Wookey A; Turner PJ; Greenhalgh JM; Eastwood M; Clarke J; Sefton C
Clin Microbiol Infect; 2004 Mar; 10(3):247-54. PubMed ID: 15008947
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
Johnson AP; Warner M; Livermore DM
J Antimicrob Chemother; 2002 Jul; 50(1):89-93. PubMed ID: 12096011
[TBL] [Abstract][Full Text] [Related]
3. Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone.
Anderegg TR; Jones RN
Int J Antimicrob Agents; 2004 Jan; 23(1):6-10. PubMed ID: 14732307
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
Jones RN; Biedenbach DJ; Anderegg TR
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):119-22. PubMed ID: 11858907
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
J Antimicrob Chemother; 2002 Aug; 50(2):271-6. PubMed ID: 12161411
[TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Zurenko GE; Yagi BH; Schaadt RD; Allison JW; Kilburn JO; Glickman SE; Hutchinson DK; Barbachyn MR; Brickner SJ
Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
[TBL] [Abstract][Full Text] [Related]
8. AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
Jones RN; Anderegg TR; Deshpande LM
Diagn Microbiol Infect Dis; 2002 May; 43(1):87-90. PubMed ID: 12052634
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
Anderegg TR; Biedenbach DJ; Jones RN
J Antimicrob Chemother; 2002 Jun; 49(6):1019-21. PubMed ID: 12039896
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the new oxazolidinone AZD2563 against Enterococci.
Eliopoulos GM; Wennersten CB; Moellering RC
Antimicrob Agents Chemother; 2002 Oct; 46(10):3273-5. PubMed ID: 12234858
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
12. Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
Baum SE; Crawford SA; McElmeel ML; Whitney CG; Jorgensen JH
Antimicrob Agents Chemother; 2002 Sep; 46(9):3094-5. PubMed ID: 12183281
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
[TBL] [Abstract][Full Text] [Related]
14. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Ednie LM; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Schaadt R; Sweeney D; Shinabarger D; Zurenko G
Antimicrob Agents Chemother; 2009 Aug; 53(8):3236-9. PubMed ID: 19528279
[TBL] [Abstract][Full Text] [Related]
16. Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
Anderegg TR; Jones RN;
Diagn Microbiol Infect Dis; 2003 Jan; 45(1):73-6. PubMed ID: 12573554
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods.
Tubau F; Fernández-Roblas R; Liñares J; Martín R; Soriano F
J Antimicrob Chemother; 2001 May; 47(5):675-80. PubMed ID: 11328783
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison.
Gemmell CG
J Antimicrob Chemother; 2001 Jul; 48(1):47-52. PubMed ID: 11474632
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Lawrence L; Danese P; DeVito J; Franceschi F; Sutcliffe J
Antimicrob Agents Chemother; 2008 May; 52(5):1653-62. PubMed ID: 18316525
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
Biedenbach DJ; Beach ML; Jones RN
Diagn Microbiol Infect Dis; 2001 Aug; 40(4):173-7. PubMed ID: 11576790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]